Medicinal Genomics specializes in advanced genomic technologies tailored for the cannabis and mushroom industries. Their offerings include a range of qPCR detection assays, such as the PathoSEEK® platform, which is designed for accurate microbial testing. This platform is notable for its AOAC accreditation across various cannabis matrices, ensuring reliability in pathogen detection. Additionally, the FemINDICAtor® assay allows for early gender identification of cannabis plants, enabling growers to optimize their resources by identifying male plants early in the cultivation process. The company also provides DNA purification kits, such as the SenSATIVAx® and Grim Reefer® kits, which facilitate the extraction of high-quality DNA for further analysis.

In addition to testing solutions, Medicinal Genomics offers genomic services that include genotyping and sequencing capabilities. Their youPCR® platform allows for efficient plant screening, enabling growers to assess genetic traits and identify novel variants quickly. The Mic and Myra semi-automated qPCR solution further streamlines the testing process, enhancing laboratory efficiency. Overall, Medicinal Genomics aims to empower growers and testing labs with innovative tools that promote clean, fast, and smart cultivation practices, ultimately contributing to the advancement of the medicinal plant industry.

United States

Medicinal Genomics uses state-of-the-art DNA technology to better understand cannabis genetics and develop products that help growers, dispensaries, and testing laboratories ensurethe safety and quality of cannabis.

Medicinal Genomics

Company Details